Product Information
RANOLAZINE ER 500 MG TABLET is a generic product labeled by Major Pharmaceuticals, priced at $0.1609 per EA under NDC 00904750604. Its NADAC has been published 70 times since Apr 23, 2025.
FDA first approved this application on Nov 30, 2020. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The Low Outlier badge above means this manufacturer's average price in the Ranolazine market falls below Q1 − 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
500 mg/1
Manufacturer
Major PharmaceuticalsNDC
00904750604
Classification
Generic
Dosage Form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
RANOLAZINEApproval Type
Generic (ANDA)
FDA Application
ANDA209953FDA Approved
11/30/2020
TE Code
AB
On Market Since
1/17/2025
Pharmacological Classes
Price Statistics
The NADAC for RANOLAZINE ER 500 MG TABLET has been published 70 times since Apr 23, 2025, and over the history we have for it it has declined 22.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1609 per EA |
|---|---|
| All-time high | $0.2071 (Jun 11, 2025) |
| All-time low | $0.1581 (Jul 22, 2026) |
| 52-week high | $0.1743 |
| 52-week low | $0.1581 |
| Median price | $0.1655 |
| Average price | $0.1738 |
| Largest weekly change | -7.5% (Aug 20, 2025) |
| Weeks tracked | 70 |
| Tracking since | Apr 23, 2025 |
Generic Alternatives
The matcher finds 12 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of RANOLAZINE ER 500 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for RANOLAZINE ER 500 MG TABLET, manufactured by Major Pharmaceuticals, is $0.1609 per EA (NDC 00904750604), effective Aug 19, 2026.
How has the price of RANOLAZINE ER 500 MG TABLET changed over time?
Over the history we have for it, the NADAC for RANOLAZINE ER 500 MG TABLET has declined 22.1%. It has been tracked across 70 weekly CMS publications since Apr 23, 2025.
What are the highest and lowest recorded NADAC prices for RANOLAZINE ER 500 MG TABLET?
Since Apr 23, 2025, the NADAC for RANOLAZINE ER 500 MG TABLET has ranged from a low of $0.1581 (Jul 22, 2026) to a high of $0.2071 (Jun 11, 2025), with a median of $0.1655 per EA.
Are there cheaper alternatives to RANOLAZINE ER 500 MG TABLET?
12 manufacturers publish a NADAC-priced product with the same active ingredient and strength as RANOLAZINE ER 500 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures RANOLAZINE ER 500 MG TABLET?
RANOLAZINE ER 500 MG TABLET (NDC 00904750604) is labeled by Major Pharmaceuticals, and CMS classifies it as a generic product.